Literature DB >> 21889528

Use of conventional care and complementary/alternative medicine among US adults with arthritis.

Katherine D Hoerster1, Dalila A Butler, Joni A Mayer, Tracy Finlayson, Linda C Gallo.   

Abstract

OBJECTIVE: Managing arthritis and co-morbid conditions is of public health importance. It is therefore critical to have a comprehensive understanding of healthcare utilization among US adults with arthritis. Thus, the present study identified characteristics associated with using both complementary and alternative medicine (CAM) and conventional healthcare.
METHOD: Using 2007 National Health Interview Survey data, multinomial logistic regression was performed to compare four categories of past year healthcare use (both CAM and conventional care vs. conventional care only, CAM only, and no healthcare use) on their potential correlates.
RESULTS: The sample (n=3850) was 62.8% female and 80.4% non-Hispanic White. Nearly half were at least 65 years old, and had used both CAM and conventional services in the previous year. The following characteristics were associated with having used neither CAM nor conventional care in the previous year (vs. having used both CAM and conventional care): being from an ethnic and racial minority group (ORs=2.44, 3.26, and 3.91) and being uninsured (OR=4.06), identifying individuals potentially at risk for unmet need.
CONCLUSION: To ensure access to comprehensive care, potentially underserved populations should be targeted with outreach (e.g., providing low-cost, accessible care, and education about benefits of various treatments for arthritis and co-morbid conditions). Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21889528     DOI: 10.1016/j.ypmed.2011.08.023

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

Review 1.  A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.

Authors:  Lu Yang; David Sibbritt; Jon Adams
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

2.  What can we learn from Steve Jobs about complementary and alternative therapies?

Authors:  Heather Greenlee; Edzard Ernst
Journal:  Prev Med       Date:  2012-01       Impact factor: 4.018

3.  Does Patient Race Affect Physical Therapy Treatment Recommendations?

Authors:  Alyson M Cavanaugh; Mitchell J Rauh
Journal:  J Racial Ethn Health Disparities       Date:  2020-10-21

4.  A National Survey of Complementary and Alternative Medicine Use for Treatment Among Asian-Americans.

Authors:  Rhea Faye D Felicilda-Reynaldo; So Yung Choi; Susan D Driscoll; Cheryl L Albright
Journal:  J Immigr Minor Health       Date:  2020-08

5.  Racial differences in symptom management approaches among persons with radiographic knee osteoarthritis.

Authors:  Shibing Yang; Rachel Jawahar; Timothy E McAlindon; Charles B Eaton; Kate L Lapane
Journal:  BMC Complement Altern Med       Date:  2012-07-06       Impact factor: 3.659

Review 6.  A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions.

Authors:  Misty Pratt; Susan Wieland; Nadera Ahmadzai; Claire Butler; Dianna Wolfe; Kusala Pussagoda; Becky Skidmore; Argie Veroniki; Patricia Rios; Andrea C Tricco; Brian Hutton
Journal:  Syst Rev       Date:  2020-04-30

7.  To Tell or Not to Tell: Shared Decision Making, CAM Use and Disclosure Among Underserved Patients with Rheumatic Diseases.

Authors:  Gwenyth R Wallen; Alyssa T Brooks
Journal:  Integr Med Insights       Date:  2012-10-03

8.  Examining racial and ethnic trends and differences in annual healthcare expenditures among a nationally representative sample of adults with arthritis from 2008 to 2016.

Authors:  Antoinette L Spector; Sneha Nagavally; Aprill Z Dawson; Rebekah J Walker; Leonard E Egede
Journal:  BMC Health Serv Res       Date:  2020-06-12       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.